La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Aether Industries Résultats passés
Passé contrôle des critères 2/6
Aether Industries has been growing earnings at an average annual rate of 12.2%, while the Pharmaceuticals industry saw earnings growing at 15.4% annually. Revenues have been growing at an average rate of 7.3% per year. Aether Industries's return on equity is 4%, and it has net margins of 13.4%.
Informations clés
12.2%
Taux de croissance des bénéfices
4.6%
Taux de croissance du BPA
| Pharmaceuticals Croissance de l'industrie | 17.5% |
| Taux de croissance des recettes | 7.3% |
| Rendement des fonds propres | 4.0% |
| Marge nette | 13.4% |
| Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
Aether Industries Limited (NSE:AETHER) Not Lagging Industry On Growth Or Pricing
Mar 09
Here's Why We Think Aether Industries (NSE:AETHER) Is Well Worth Watching
Sep 29Results: Aether Industries Limited Beat Earnings Expectations And Analysts Now Have New Forecasts
Jul 29If EPS Growth Is Important To You, Aether Industries (NSE:AETHER) Presents An Opportunity
Jun 09With Aether Industries Limited (NSE:AETHER) It Looks Like You'll Get What You Pay For
Apr 19Aether Industries' (NSE:AETHER) Profits Appear To Have Quality Issues
Nov 19Ventilation des recettes et des dépenses
Comment Aether Industries gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 6,171 | 826 | 406 | 0 |
| 31 Mar 24 | 5,982 | 825 | 386 | 0 |
| 31 Dec 23 | 6,678 | 1,215 | 367 | 0 |
| 30 Sep 23 | 6,795 | 1,391 | 391 | 0 |
| 30 Jun 23 | 6,555 | 1,296 | 355 | 0 |
| 31 Mar 23 | 6,544 | 1,304 | 351 | 0 |
| 31 Dec 22 | 6,175 | 1,189 | 313 | 0 |
| 30 Sep 22 | 6,016 | 1,092 | 291 | 0 |
| 30 Jun 22 | 6,052 | 1,072 | 281 | 0 |
| 31 Mar 22 | 5,927 | 1,089 | 272 | 0 |
| 31 Dec 21 | 5,610 | 1,058 | 278 | 0 |
| 30 Sep 21 | 5,186 | 956 | 268 | 0 |
| 30 Jun 21 | 4,884 | 869 | 238 | 0 |
| 31 Mar 21 | 4,517 | 711 | 228 | 0 |
| 31 Mar 20 | 3,026 | 400 | 138 | 0 |
| 31 Mar 19 | 2,019 | 233 | 110 | 0 |
| 31 Mar 18 | 1,087 | 78 | 88 | 0 |
Des revenus de qualité: AETHER has high quality earnings.
Augmentation de la marge bénéficiaire: AETHER's current net profit margins (13.4%) are lower than last year (19.8%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: AETHER's earnings have grown by 12.2% per year over the past 5 years.
Accélération de la croissance: AETHER's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: AETHER had negative earnings growth (-36.3%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (19.3%).
Rendement des fonds propres
ROE élevé: AETHER's Return on Equity (4%) is considered low.